Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

GSH prevents cisplatin-induced toxicity

Sep. 9, 1997

Treatment for preleukemic disorder from Milkhaus enters phase III

Sep. 9, 1997

GeneMedicine begins phase I testing of IL-2 Cancer Gene Medicine

Sep. 8, 1997

Novel integrin receptor antagonists from DuPont Merck

Sep. 8, 1997

Antimitotic cryptophycin compounds

Sep. 5, 1997

Vitamin D derivatives as progesterone antagonists

Sep. 5, 1997

New antitumor agents from Kyorin and Sagami

Sep. 5, 1997

DepoTech seeks Canadian approval for DepoCyt

Sep. 4, 1997

AccuSite approved in Ireland and The Netherlands

Sep. 4, 1997

Vitronectin receptor antagonists described by Merck KGaA

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...